Literature DB >> 26304665

Clinical Impact of Changes in Left Ventricular Function After Aortic Valve Replacement: Analysis From 3112 Patients.

Dai Une1, Laura Mesana1, Vincent Chan1, Michelle Maklin1, Ryan Chan1, Roy G Masters1, Thierry G Mesana1, Marc Ruel2.   

Abstract

BACKGROUND: Our objectives were to identify correlates of mortality and congestive heart failure after aortic valve replacement (AVR) according to preoperative left ventricular (LV) function and to describe the incidence, time course, and correlates of LV recovery and mass regression postoperatively. METHODS AND
RESULTS: A total of 3112 patients with AVR were assessed in a follow-up clinic with echocardiography (median follow-up, 6.0 years). At operation, their mean age was 67.8±13.4 years, one third were female, and 29% had LV dysfunction (ejection fraction <50%). In severe patients with severe aortic stenosis and LV dysfunction, transaortic valve mean pressure gradient <40 mm Hg, longer cardiopulmonary bypass duration, and prosthesis-patient mismatch (indexed effective orifice area ≤0.85 cm(2)/m(2)) were independent correlates of the composite outcome of death or congestive heart failure after AVR. In patients with severe aortic regurgitation and LV dysfunction, older age and higher preoperative LV mass were identified. LV recovery correlated with better survival and freedom from heart failure in patients with aortic stenosis. Maximum LV mass regression took 24 months in patients with aortic stenosis and nearly 5 years with aortic regurgitation; independent correlates included smaller LV end-systolic diameter in patients with aortic stenosis and low New York Heart Association class with aortic regurgitation.
CONCLUSIONS: Incomplete LV recovery, prosthesis-patient mismatch, low transaortic valve pressure gradient, and higher LV mass are associated with increased mortality or heart failure after AVR in patients with LV dysfunction. Higher LV end-systolic diameter and symptoms correlate with less LV mass regression, which takes at least 2 years. These findings help surgeons and cardiologists refine the indications, timing, prognostication, and follow-up of patients before and after AVR.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  aortic valve; hypertrophy, left ventricular; survival; ventricular dysfunction, left; ventricular remodeling

Mesh:

Year:  2015        PMID: 26304665     DOI: 10.1161/CIRCULATIONAHA.115.015371

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  23 in total

1.  Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement.

Authors:  Taku Inohara; Pratik Manandhar; Andrzej S Kosinski; Roland A Matsouaka; Shun Kohsaka; Robert J Mentz; Vinod H Thourani; John D Carroll; Ajay J Kirtane; Joseph E Bavaria; David J Cohen; Todd L Kiefer; Jeffrey G Gaca; Samir R Kapadia; Eric D Peterson; Sreekanth Vemulapalli
Journal:  JAMA       Date:  2018-12-04       Impact factor: 56.272

2.  The impact of age on the postoperative response of the diastolic function and left ventricular mass regression after surgical or transcatheter aortic valve replacement for severe aortic stenosis.

Authors:  Teruya Nakamura; Koichi Toda; Toru Kuratani; Shigeru Miyagawa; Yasushi Yoshikawa; Satsuki Fukushima; Shunsuke Saito; Yoshiki Sawa
Journal:  Surg Today       Date:  2016-12-24       Impact factor: 2.549

3.  Less pronounced reverse left ventricular remodeling in patients with bicuspid aortic stenosis treated with transcatheter aortic valve replacement compared to tricuspid aortic stenosis.

Authors:  Tian-Yuan Xiong; Xi Wang; Yi-Jian Li; Yan-Biao Liao; Zhen-Gang Zhao; Xin Wei; Yuan-Ning Xu; Ming-Xia Zheng; Xuan Zhou; Yong Peng; Jia-Fu Wei; Yuan Feng; Mao Chen
Journal:  Int J Cardiovasc Imaging       Date:  2018-06-18       Impact factor: 2.357

4.  Induction of cardiomyocyte proliferation and angiogenesis protects neonatal mice from pressure overload-associated maladaptation.

Authors:  Mona Malek Mohammadi; Aya Abouissa; Isyatul Azizah; Yinuo Xie; Julio Cordero; Amir Shirvani; Anna Gigina; Maren Engelhardt; Felix A Trogisch; Robert Geffers; Gergana Dobreva; Johann Bauersachs; Joerg Heineke
Journal:  JCI Insight       Date:  2019-07-23

5.  Arterial Stiffness in Aortic Stenosis and the Impact of Aortic Valve Replacement.

Authors:  Oscar Plunde; Magnus Bäck
Journal:  Vasc Health Risk Manag       Date:  2022-03-08

6.  Outcomes of surgical aortic valve replacement for mixed aortic valve disease.

Authors:  Jennifer L Philip; Tiffany Zens; Lucian Lozonschi; Nilto C De Oliveira; Satoru Osaki; Takushi Kohmoto; Shahab A Akhter; Paul C Tang
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

7.  Reverse left ventricular remodelling after aortic valve replacement for severe aortic insufficiency.

Authors:  Teppei Toya; Satsuki Fukushima; Yusuke Shimahara; Shingo Kasahara; Junjiro Kobayashi; Tomoyuki Fujita
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-05-27

8.  Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries.

Authors:  Shmuel Chen; Bjorn Redfors; Tamim Nazif; Ajay Kirtane; Aaron Crowley; Ori Ben-Yehuda; Samir Kapadia; Matthew T Finn; Sachin Goel; Brian R Lindman; Maria C Alu; Katherine H Chau; Vinod H Thourani; Torsten P Vahl; Pamela S Douglas; Susheel K Kodali; Martin B Leon
Journal:  Eur Heart J       Date:  2020-02-21       Impact factor: 35.855

9.  Computed tomography angiography-derived extracellular volume fraction predicts early recovery of left ventricular systolic function after transcatheter aortic valve replacement.

Authors:  Donghee Han; Balaji Tamarappoo; Eyal Klein; Jeffrey Tyler; Tarun Chakravarty; Yuka Otaki; Robert Miller; Evann Eisenberg; Rebekah Park; Siddharth Singh; Takahiro Shiota; Robert Siegel; Jasminka Stegic; Tracy Salseth; Wen Cheng; Damini Dey; Louise Thomson; Daniel Berman; Raj Makkar; John Friedman
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2021-01-22       Impact factor: 9.130

10.  Nitric Oxide Decreases Acute Kidney Injury and Stage 3 Chronic Kidney Disease after Cardiac Surgery.

Authors:  Chong Lei; Lorenzo Berra; Emanuele Rezoagli; Binglan Yu; Hailong Dong; Shiqiang Yu; Lihong Hou; Min Chen; Wensheng Chen; Hongbing Wang; Qijun Zheng; Jie Shen; Zhenxiao Jin; Tao Chen; Rong Zhao; Emily Christie; Venkata S Sabbisetti; Francesco Nordio; Joseph V Bonventre; Lize Xiong; Warren M Zapol
Journal:  Am J Respir Crit Care Med       Date:  2018-11-15       Impact factor: 30.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.